3 Axis Advisors

3 Axis Advisors is an elite, highly specialized consultancy that partners with private and government sector organizations to solve complex, systemic problems and propel industry reform through data driven advocacy. With a primary focus on identifying and analyzing U.S. drug supply chain inefficiencies and cost drivers, 3 Axis Advisors offers unparalleled expertise in project design, data aggregation and analysis, investigative research, and public education. 3 Axis Advisors arms clients with independent data analysis needed to spur change and innovation within their respective industries. 3 Axis Advisors co-founders were instrumental in exposing the drug pricing distortions and supply chain inefficiencies embedded in Ohio’s Medicaid managed care program that ultimately uncovered more than $244 million in secret prescription drug mark-ups and inspired a national reckoning on hidden cost drivers within the prescription drug supply chain. They are also the co-founders of 46brooklyn Research, a nonprofit organization dedicated to improving the transparency and accessibility of drug pricing data for the American public. To learn more about 3 Axis Advisors, visit ww.3axisadvisors.com To learn more about 46brooklyn Research, visit